» Articles » PMID: 30458287

MiR-202-3p Regulates Interleukin-1β-induced Expression of Matrix Metalloproteinase 1 in Human Nucleus Pulposus

Overview
Journal Gene
Specialty Molecular Biology
Date 2018 Nov 21
PMID 30458287
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs), small noncoding RNA molecules, have emerged as important factors during intervertebral disc degeneration. This study was to determine whether miR-202-3p regulates interleukin-1β (IL-1β)-induced expression of matrix metalloproteinase 1 (MMP-1) in human nucleus pulposus (NP) cells. Human NP cells were stimulated with IL-1β in vitro. MicroRNA arrays were used to determine the expression profile of 1971 human miRNAs and the miRNAs targets were identified using bioinformatics. In IL-1β-stimulated NP cells, 10 microRNAs were down-regulated, 2 microRNAs were up-regulated. There was a significant reduction in hsa-miR-202-3p (miR-202-3p) expression in the severe degenerative disc compared with mild degenerative disc. Down-regulation of miR-202-3p expression by IL-1β was correlated with up-regulation of MMP-1 expression in human NP cells. IL-1β-induced activation of MAP kinase (MAPK) and nuclear factor-κB (NF-κB) decreased miR-202-3p expression and induced MMP-1 expression. MiR-202-3p suppressed IL-1β-induced MMP-1 production. Conversely, treatment with anti-miR-202-3p remarkably increased MMP-1 production. In addition, mutation of the miR-202-3p binding site in the 3'-UTR of MMP-1 mRNA abolished miR-202-3p-mediated repression of reporter activity. Functional analysis showed that miR-202-3p could decrease type II collagen degradation, whereas overexpression of MMP-1 by Lentiviral-shMMP-1 abolished the effect of miR-202-3p on type II collagen degradation. These results suggest that miR-202-3p is an important regulator of MMP-1 in human nucleus pulposus and may contribute to the development of intervertebral disc degeneration.

Citing Articles

Progress in regulating inflammatory biomaterials for intervertebral disc regeneration.

Xiang H, Zhao W, Jiang K, He J, Chen L, Cui W Bioact Mater. 2024; 33:506-531.

PMID: 38162512 PMC: 10755503. DOI: 10.1016/j.bioactmat.2023.11.021.


High-Tech Methods of Cytokine Imbalance Correction in Intervertebral Disc Degeneration.

Shnayder N, Ashhotov A, Trefilova V, Novitsky M, Medvedev G, Petrova M Int J Mol Sci. 2023; 24(17).

PMID: 37686139 PMC: 10487844. DOI: 10.3390/ijms241713333.


tsRNA-04002 alleviates intervertebral disk degeneration by targeting PRKCA to inhibit apoptosis of nucleus pulposus cells.

Pan J, Liu Z, Shen B, Xu J, Dai G, Xu W J Orthop Surg Res. 2023; 18(1):413.

PMID: 37287061 PMC: 10249188. DOI: 10.1186/s13018-023-03878-3.


Role of lncRNA MAGI2-AS3 in lipopolysaccharide-induced nucleus pulposus cells injury by regulating miR-374b-5p/interleukin-10 axis.

Yu J, Li C Immun Inflamm Dis. 2023; 11(4):e772.

PMID: 37102649 PMC: 10108685. DOI: 10.1002/iid3.772.


Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease.

Christopoulou M, Papakonstantinou E, Stolz D Int J Mol Sci. 2023; 24(4).

PMID: 36835197 PMC: 9966421. DOI: 10.3390/ijms24043786.